PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555484
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1555484
Hepato-Pancreatico-Biliary (HPB) Surgery Surgical Products Market size was valued at USD 4,789.45 Million in 2023, expanding at a CAGR of 8.1% from 2024 to 2032.
Hepato-Pancreatico-Biliary (HPB) surgery refers to a specialized field of surgery focused on treating conditions affecting the liver, pancreas, and biliary system which includes the bile ducts and gallbladder. Surgical products related to HPB surgery are tools and devices specifically designed to assist in performing complex procedures involving these organs.
Hepato-Pancreatico-Biliary (HPB) Surgery Surgical Products Market- Market Dynamics
Growing incidence of HPB disorders and development in surgical techniques is expected to propel market demand
The increasing prevalence of diseases such as liver cancer, pancreatic cancer, and biliary tract disorders drives demand for surgical products used in HPB surgeries. The older adult population is more susceptible to HPB disorders, leading to higher demand for surgical interventions and related products. Technological advancements, such as minimally invasive surgical techniques like laparoscopic and robotic-assisted surgery are fueling the need for specialized surgical tools and equipment.
Continuous innovations in surgical technologies, including enhanced imaging systems, surgical robots, and improved materials for surgical instruments, drive the growth of the market. An increasing number of research and development efforts lead to the introduction of new and improved surgical products, catering to evolving needs and preferences in HPB surgery. Further, an increase in the number of HPB surgeries being performed, both for elective and emergency cases, drives the demand for related surgical products.
Hepato-Pancreatico-Biliary (HPB) Surgery Surgical Products Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.1% over the forecast period (2024-2032)
Based on Product segmentation, the electrosurgery instruments segment was predicted to show maximum market share in the year 2023, owing to its better advantages in treating pancreas & liver surgeries.
Based on Indication segmentation, the liver cancer segment was the leading Indication in 2023, owing to the prevalence of liver cirrhosis, hepatocellular carcinoma, etc.
Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, owing to increasing HPB surgeries in younger & older adult groups.
Based on region, North America was the leading revenue generator in 2023, due to the early adoption of new tech and easy availability of surgery products.
The Global Hepato-Pancreatico-Biliary (HPB) Surgery Surgical Products Market is segmented based on Product, Indication, End User, and Region.
The market is divided into ten categories based on Product: electrosurgery instruments, endoscopes, visualization and robotic surgical systems, hand instruments, access instruments, surgical suture and stapler devices, energy/vessel sealing devices, fluid management systems, stents and others. The electrosurgery instruments segment dominates the market. The electrosurgery instruments are highly durable and effective in HPB surgeries.
The market is divided into eight categories based on Indication: liver cancer, pancreatic cancer, bile duct cancer, gallstones, pancreatitis, cirrhosis, cholecystitis, and others. The liver cancer segment dominates the market. The growing incidence of liver disorders and laparoscopy is boosting segment growth.
The market is divided into three categories based on End Users: hospitals, ambulatory surgical centers, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing demand for surgical products and rapid treatment at hospitals is promoting market growth.
Hepato-Pancreatico-Biliary (HPB) Surgery Surgical Products Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, primarily the United States and Canada, is a leader in the global market. These countries have advanced healthcare systems with high adoption rates of cutting-edge surgical technologies. The presence of major medical device companies and a high prevalence of HPB disorders contribute to a significant market share. In Europe, countries like Germany, France, and the UK have well-established healthcare systems and high standards of medical care. There's a strong emphasis on technological advancements and minimally invasive surgeries.
The Hepato-Pancreatico-Biliary (HPB) Surgery Surgical Products (SITS) market is formulated by strong competition and rapid technological advancements. Key players are leveraging innovation, strategic partnerships, and geographic expansion to maintain and grow their market positions. Companies are focusing on products that improve patient outcomes, including reducing complications and enhancing recovery. This includes advancements in hemostatic agents, surgical sutures, and robotic-assisted systems. In addition, companies are expanding their presence in emerging markets, such as Asia-Pacific and Latin America, where rising healthcare investments and increasing prevalence of HPB disorders offer growth opportunities.
In August 2023, Boston Scientific Corporation received approval for the POLARxTM Cryoablation System from the U.S. Food and Drug Administration (FDA). The new system uses the POLARx FIT Cryoablation Balloon Catheter.